Published in Neuro Endocrinol Lett on November 01, 2007
Biochemistry of interferons and their actions. Annu Rev Biochem (1982) 6.89
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature (1979) 3.43
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med (2001) 3.40
The interferon system. A bird's eye view of its biochemistry. J Biol Chem (1992) 3.39
Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A (1976) 3.24
Mechanism of protein biosynthesis. Bacteriol Rev (1969) 2.57
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease. Science (1981) 2.38
Structure and expression of cloned murine IFN-alpha genes. Nucleic Acids Res (1983) 2.35
Nucleotide sequence of a ribosome attachment site of bacteriophage f2 RNA. Biochem Biophys Res Commun (1970) 2.32
A dielectric polymer with high electric energy density and fast discharge speed. Science (2006) 2.30
Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A (1978) 2.22
Formylmethionyl-tRNA dependence of amino acid incorporation in extracts of trimethoprim-treated Escherichia coli. Science (1966) 1.98
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med (1992) 1.85
On the relation between ribonucleic acid synthesis and peptide chain initiation in E. coli. Proc Natl Acad Sci U S A (1966) 1.83
Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. J Biol Chem (1978) 1.81
Actin cytoskeleton and budding pattern are altered in the yeast rvs161 mutant: the Rvs161 protein shares common domains with the brain protein amphiphysin. Mol Gen Genet (1995) 1.78
Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70
Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun (1978) 1.70
Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Wegener's granulomatosis causing deafness. J Laryngol Otol (1973) 1.56
The young adolescent as an obstetric risk. Am J Obstet Gynecol (1969) 1.54
Interferons as gene activators. Cloning of the 5' terminus and the control segment of an interferon activated gene. J Biol Chem (1986) 1.53
Transfusion-requiring haemolytic anaemia after mitral-valve repair. Lancet (1996) 1.51
Interaliasing distance of the flow convergence surface for determining mitral regurgitant volume: a validation study in a chronic animal model. J Am Coll Cardiol (2001) 1.46
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Interferon action: two (2'-5')(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon. Cell (1983) 1.37
Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37
A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A (1992) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Translation of in vitro synthesized reovirus messenger RNAs into proteins of the size of reovirus capsid proteins in a mouse L cell extract. Biochem Biophys Res Commun (1972) 1.33
The formation of glycosidic bonds in yeast glycoproteins. Intracellular localisation of the reactions. Arch Microbiol (1977) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Interferon, double-stranded RNA, and RNA degradation. Isolation of homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells. J Biol Chem (1980) 1.30
Movement of the ribosome along the messenger ribonucleic acid during protein synthesis. Biochemistry (1971) 1.30
Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s). Biochem Biophys Res Commun (1973) 1.30
Mouse interferons: amino terminal amino acid sequences of various species. Science (1980) 1.30
Polynucleotide-dependent incorporation of amino acids in a cell-free system from thermophilic bacteria. J Biol Chem (1966) 1.29
Mouse interferons enhance the accumulation of a human HLA RNA and protein in transfected mouse and hamster cells. J Biol Chem (1982) 1.29
Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J Biol Chem (1989) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol (1996) 1.26
Purification of interferon from mouse Ehrlich ascites tumor cells. J Biol Chem (1978) 1.23
Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry (1973) 1.23
On the recognition of serine transfer RNA's specific for unrelated codons by the same seryl-transfer RNA synthetase. Proc Natl Acad Sci U S A (1968) 1.23
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells. J Gen Virol (1973) 1.17
The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription. EMBO J (1999) 1.17
Transcripts of human HLA gene fragments lacking the 5'-terminal region in transfected mouse cells. Proc Natl Acad Sci U S A (1984) 1.16
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
On three complementary amino acid polymerization factors from Bacillus stearothermophilus: separation of a complex containing two of the factors, guanosine-5'-triphosphate and aminoacyl-transfer RNA. Proc Natl Acad Sci U S A (1968) 1.15
Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem (1977) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Formation and characteristics of reovirus subviral particles in interferon-treated mouse L cells. Nucleic Acids Res (1976) 1.12
Interferon, double-stranded RNA, and RNA degradation: activation of an endonuclease by (2'-5')An. Proc Natl Acad Sci U S A (1979) 1.12
Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol (1975) 1.11
Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J Interferon Res (1993) 1.11
Engineering pathways for malate degradation in Saccharomyces cerevisiae. Nat Biotechnol (1997) 1.11
Peptide chain elongation: discrimination against the initiator transfer RNA by microbial amino-acid polymerization factors. Nature (1968) 1.11
Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J Virol (1988) 1.10
Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol (1977) 1.08
Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol (1991) 1.08
Interferon action: transcriptional control of a gene specifying a 56,000-Da protein in Ehrlich ascites tumor cells. Virology (1985) 1.08
Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect (2006) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Systemic malignancies presenting as primary osteolytic lesion. Bratisl Lek Listy (2009) 1.07
Peptide chain elongation. Role of the S 1 factor in the pathway from S 3 -guanosine diphosphate complex to aminoacyl transfer ribonucleic acid-S 3 -guanosine triphosphate complex. Biochemistry (1971) 1.07
Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells. Biochem Biophys Res Commun (1975) 1.06
Peptide chain elongation. Cold Spring Harb Symp Quant Biol (1969) 1.06
Release of the inhibition of messenger RNA translation in extracts of interferon-treated Ehrlich ascites tumor cells by added transfer RNA. Biochem Biophys Res Commun (1974) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Translation of reovirus messenger ribonucleic acids synthesized in vitro into reovirus proteins in a mouse L cell extract. Arch Biochem Biophys (1973) 1.04
Selective inhibition of viral protein accumulation in interferon-treated cells; nondiscriminate inhibition of the translation of added viral and cellular messenger RNAs in their extracts. Virology (1974) 1.04
Inhibition of E2F-mediated transcription by p202. EMBO J (1996) 1.02
Interferon action: effects of mouse alpha and beta interferons on rosette formation, phagocytosis, and surface-antigen expression of cells of the macrophage-type line RAW 309Cr.1. Cell Immunol (1982) 1.01
Apparent changes in ribosome conformation during protein synthesis. Centrifugation at high speed distorts initiation, pretranslocaton, and posttranslocation complexes to a different extent. Biochemistry (1972) 1.00
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol (2001) 1.00
The antioxidative properties of Holy basil and Galangal in cooked ground pork. Meat Sci (2005) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
[Patients in a state of agitation at the admission service of a Rouen hospital emergency department]. Presse Med (1999) 0.99
Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J Biol Chem (1995) 0.99
Interferon action: nucleolar and nucleoplasmic localization of the interferon-inducible 72-kD protein that is encoded by the Ifi 204 gene from the gene 200 cluster. J Cell Biol (1992) 0.99
The mae1 gene of Schizosaccharomyces pombe encodes a permease for malate and other C4 dicarboxylic acids. Yeast (1995) 0.97
Interferons as gene activators. Characteristics of an interferon-activatable enhancer. J Biol Chem (1987) 0.97
Enzymology of interferon action--a short survey. Methods Enzymol (1981) 0.97
Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase. J Biol Chem (1981) 0.96
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. Ann Oncol (2008) 0.96
Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. J Biol Chem (1980) 0.96
Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics (1999) 0.96
MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol Cell Biol (2000) 0.96
Inhibition of peptide-chain initiation in Escherichia coli by hydroxylamine and effects on ribonucleic acid synthesis. Biochemistry (1970) 0.95
PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J Interferon Res (1993) 0.95
Peptide chain elongation: GTP cleavage catalysed by factors binding aminoacyl-transfer RNA to the ribosome. Nature (1969) 0.95
beta-Interferon alters the pattern of proteins secreted from quiescent and platelet-derived growth factor-treated BALB/c-3T3 cells. J Biol Chem (1985) 0.94
Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes. Scand J Infect Dis (2005) 0.94